Thank you, Mr. Chair.
Good morning and thank you for being here with us for this first meeting with witnesses, with the exception of the officials who appeared before us last week.
Dr. Kilby, I understand from your testimony that, as of now, there are enough drugs for AIDS on the African market to meet the needs as expressed by your partners working in the field with the affected groups. But you are telling us that there could now be an access problem since the 2010 objective is to treat 5.2 million patients. That's what I understood from your testimony.
During our last meeting, we realized that India was an important, if not the most important, supplier of antiretroviral medications for African countries. Is it because India's production capacity is no longer sufficient to meet the demand that you feel problems could arise right now?